Issue navigation
Volume 9, Issue 2, April 2025
COMMENTARY
AI meets informed consent: a new era for clinical trial communication
JNCI Cancer Spectrum, Volume 9, Issue 2, April 2025, pkaf028, https://doi.org/10.1093/jncics/pkaf028
ARTICLES
Do trial benefits predict real-world gains in metastatic castration resistant prostate cancer
JNCI Cancer Spectrum, Volume 9, Issue 2, April 2025, pkaf018, https://doi.org/10.1093/jncics/pkaf018
Functional outcomes after primary vs delayed robot-assisted radical prostatectomy following active surveillance
JNCI Cancer Spectrum, Volume 9, Issue 2, April 2025, pkaf020, https://doi.org/10.1093/jncics/pkaf020
Parental loss at age birth to 21 years and daughters’ breast cancer and tumor characteristics
JNCI Cancer Spectrum, Volume 9, Issue 2, April 2025, pkaf004, https://doi.org/10.1093/jncics/pkaf004
Inequities in palliative care delivery to patients with HIV and stage IV cancers in the United States (2004-2020)
JNCI Cancer Spectrum, Volume 9, Issue 2, April 2025, pkae118, https://doi.org/10.1093/jncics/pkae118
Tumor localization strategies of multicancer early detection tests: a quantitative assessment
JNCI Cancer Spectrum, Volume 9, Issue 2, April 2025, pkaf011, https://doi.org/10.1093/jncics/pkaf011
Social determinants of health and variability in treatment for patients with early-stage non-small cell lung cancer
JNCI Cancer Spectrum, Volume 9, Issue 2, April 2025, pkae117, https://doi.org/10.1093/jncics/pkae117
Alcohol consumption, polygenic risk score, and the risk of colorectal neoplasia
JNCI Cancer Spectrum, Volume 9, Issue 2, April 2025, pkaf017, https://doi.org/10.1093/jncics/pkaf017
Antibiotic treatment and survival in patients with resected, early-stage pancreatic ductal adenocarcinoma receiving chemotherapy
JNCI Cancer Spectrum, Volume 9, Issue 2, April 2025, pkaf024, https://doi.org/10.1093/jncics/pkaf024
Prostate cancer screening in the Middle East and North Africa: a cross-sectional study on current practices
JNCI Cancer Spectrum, Volume 9, Issue 2, April 2025, pkaf019, https://doi.org/10.1093/jncics/pkaf019
Revisiting surrogacy of pathological complete response for long-term survival in triple-negative breast cancer
JNCI Cancer Spectrum, Volume 9, Issue 2, April 2025, pkaf022, https://doi.org/10.1093/jncics/pkaf022
Genome-wide association study and Mendelian randomization analyses reveal insights into bladder cancer etiology
JNCI Cancer Spectrum, Volume 9, Issue 2, April 2025, pkaf014, https://doi.org/10.1093/jncics/pkaf014
Multi-gene risk score for prediction of clinical outcomes in treatment-naïve metastatic castrate-resistant prostate cancer
JNCI Cancer Spectrum, Volume 9, Issue 2, April 2025, pkaf025, https://doi.org/10.1093/jncics/pkaf025
The use of large language models to enhance cancer clinical trial educational materials
JNCI Cancer Spectrum, Volume 9, Issue 2, April 2025, pkaf021, https://doi.org/10.1093/jncics/pkaf021
Forward momentum: progressive change through diversity equity and inclusion initiatives in academic health care
JNCI Cancer Spectrum, Volume 9, Issue 2, April 2025, pkaf029, https://doi.org/10.1093/jncics/pkaf029
Easy ensemble classifier-group and intersectional fairness and threshold (EEC-GIFT): a fairness-aware machine learning framework for lung cancer screening eligibility using real-world data
JNCI Cancer Spectrum, Volume 9, Issue 2, April 2025, pkaf030, https://doi.org/10.1093/jncics/pkaf030
MINIREVIEW
Screening for comprehensive social needs in patients with cancer: a narrative review
JNCI Cancer Spectrum, Volume 9, Issue 2, April 2025, pkaf012, https://doi.org/10.1093/jncics/pkaf012
